Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04706234Recruiting

Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

Role: lead

NCT05139342Not ApplicableUnknown

Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients

Role: lead

NCT03882502Not ApplicableUnknown

Electrical Stimulation in Traumatic Brain Injury (TBI) Induced Aphasia

Role: collaborator

All 3 trials loaded